SCHEMBL20748798

SCHEMBL20748798

CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(Cc1ccccc1)C(=O)O)OC)N(C)C(=O)CNC(=O)C(C(C)C)N(C)CCCN

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SSTR2 P30874 2/20 0.39
CYP3A4 P08684 1/20 0.39
CTSD P07339 2/20 0.36
CTSE P14091 2/20 0.36
BACE1 P56817 1/20 0.36
REN P00797 4/20 0.35
ACE P12821 3/20 0.34
ANPEP P15144 1/20 0.34
LNPEP Q9UIQ6 1/20 0.34
FOLH1 Q04609 2/20 0.34
APLNR P35414 1/20 0.33
RAMP1 O60894 1/20 0.33
CALCRL Q16602 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
MME P08473 1/20 0.33
CPA1 P15085 1/20 0.33
ACE2 Q9BYF1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21444709 0.98 CYP3A4 (0.39) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL21103427 0.96 REN (0.40) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL20902069 0.94 CYP3A4 (0.39) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL21699517 0.94 SSTR2 (0.37) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL21699526 0.94 CYP3A4 (0.39) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL21699557 0.92 SSTR2 (0.38) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL19841574 0.92 CYP3A4 (0.37) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL15811693 0.92 CYP3A4 (0.37) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL22419930 0.92 CYP3A4 (0.37) SSTR2CYP3A4CTSDCTSEBACE1
SCHEMBL18602020 0.92 CYP3A4 (0.37) SSTR2CYP3A4CTSDCTSEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3607996-B1 ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER PF MEDICAMENT (FR) 2023-01-04 EP disclosed
EP-3607996-A1 ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER PIERRE FABRE MEDICAMENT (FR) 2020-02-12 EP disclosed
EP-3498301-A1 KIT COMPRISING IGF-1R ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER PIERRE FABRE MEDICAMENT (FR) 2019-06-19 EP disclosed
EP-3134124-B1 IGF-1R ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER PF MEDICAMENT (FR) 2019-02-20 EP disclosed